Oral Contraceptive Switch Advocates Reject User Age As Approval Factor
This article was originally published in The Pink Sheet
Executive Summary
FDA could soon receive an NDA from non-profit research group Ibis Reproductive Health and HRA Pharma, for an oral contraceptive switch in the US.